Hosted on MSN1y
Don't use smartwatches and rings that claim to measure blood sugar without needles, the FDA warns
pair with FDA-authorized wearable devices like the Dexcom G7, which uses needles to read your blood sugar levels. Getting a smartwatch or a smart ring to monitor blood sugar levels without ...
pharmaphorum11mon
FDA clears first OTC glucose biosensor, from Dexcom
It takes the form of a patch with a small needle that pierces the skin and is worn on the back of the arm for up to 15 days, communicating glucose readings to a smartphone. Dexcom is focused on ...
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose levels in real-time in non-diabetics.
pharmaphorum3d
Abbott’s OTC glucose monitor ‘will grow the market’
Just a few weeks after Dexcom’s Stelo became the first over ... Like Stelo, Lingo takes the form of a patch with a tiny needle that pierces the skin and is worn on the back of the arm for ...
Everyday Health on MSN11mon
FDA Approves the First Over-the-Counter Continuous Glucose Monitor (CGM)
Dexcom, the maker of the G6 and G7 continuous ... The Stelo sensor works by penetrating the skin with a thin, flexible needle ...
Nasdaq8d
DexCom: Revenue Up, EPS Misses Mark
DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue ...
Kiplinger7mon
Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know
Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...